أحد الأهداف الرئيسية لـ Life4me + - منع حالات الإصابة الجديدة بفيروس نقص المناعة البشرية والأمراض المنقولة جنسياً الأخرى والتهاب الكبد الوبائي والسل.

يساعد التطبيق على تأسيس اتصال مجهول بين الأطباء والمصابين بفيروس نقص المناعة البشرية. انها تسمح لك بسهولة تنظيم جدول الدواء الخاص بك وإعداد تذكير خفية وشخصية.

جميع الأخبار / ديسمبر 2017

أرشيف

✕

١٥ ديسمبر ٢٠١٧

3905

Brazil Offers Free Truvada to Prevent HIV Among Youth

Brazil Offers Free Truvada to Prevent HIV Among Youth

The Brazilian Health Ministry is paying Gilead Sciences, the maker of the drug, about 75 cents a dose; in the United States, a month’s supply costs about $1,600.

١٥ ديسمبر ٢٠١٧

3660

Progress on the 'Third 90' target is not a reliable guide to HIV transmission potential

Progress on the 'Third 90' target is not a reliable guide to HIV transmission potential

Measuring the proportion of people with an undetectable viral load may be lulling health policymakers into a false sense of security in their efforts to control HIV transmission through comprehensive treatment, according to a new study from South Africa.

١٤ ديسمبر ٢٠١٧

3724

National Platform for Key Communities established in Ukraine

National Platform for Key Communities established in Ukraine

The platform’s priorities will include influencing policies and decision-making processes, the development of a package of HIV prevention services that respond to the needs of key populations and responding to discrimination.

١٤ ديسمبر ٢٠١٧

4245

Half the world lacks access to essential health services

Half the world lacks access to essential health services

At least half of the world’s population cannot obtain essential health services, according to a new report from the World Bank and WHO. And each year, large numbers of households are being pushed into poverty because they must pay for health care out of their own pockets.

١٣ ديسمبر ٢٠١٧

3626

New tuberculosis drugs possible with understanding of old antibiotic

New tuberculosis drugs possible with understanding of old antibiotic

Only by truly understanding molecular and cellular events caused by antibiotics or in response to their presence will we truly understand how to make improved drugs, which are much needed in face of the current threat of antibiotic resistance.

١٣ ديسمبر ٢٠١٧

4028

The New Plan to ‘Make HIV History’ in Australia

The New Plan to ‘Make HIV History’ in Australia

The new plan would give wider access to a highly effective preventative drug named PrEP and deliver it to at-risk communities around Australia. It would also save $2 billion in future public health costs.

١٢ ديسمبر ٢٠١٧

3727

BRICS Countries Are Making Progress Towards Universal Health Coverage

BRICS Countries Are Making Progress Towards Universal Health Coverage

The emerging economies of Brazil, Russia, India, China and South Africa — representing almost half the world’s population — are all taking steps toward Universal Health Coverage.

١٢ ديسمبر ٢٠١٧

3893

Kazatchkine appointed UNAIDS Special Adviser

Kazatchkine appointed UNAIDS Special Adviser

Michel Kazatchkine appointed UNAIDS Special Adviser on HIV, Tuberculosis and Hepatitis C in Eastern Europe and Central Asia.

١١ ديسمبر ٢٠١٧

3550

New hepatitis C therapy approved in UK

New hepatitis C therapy approved in UK

Maviret (Glecaprevir-pibrentasvir) has been recommended for adults with chronic hepatitis C. The treatment is an additional option suitable for all genotypes, with or without scarring of the liver, and in people who are untreated or have been treated before with interferon-based ...

١١ ديسمبر ٢٠١٧

3492

Grantmaking for HIV Totaled a Record $680 Million

Grantmaking for HIV Totaled a Record $680 Million

Global philanthropic support for HIV/AIDS initiatives totaled a record $680 million in 2016. The top twenty funders accounted for 87 percent of 2016 resources. The top recipient of country-level philanthropic funding for HIV/AIDS initiatives was the U.S.

1 2 3 4 5